ClinicalTrials.Veeva

Menu

Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow

E

E-DA Hospital

Status

Unknown

Conditions

Type A Botulinum Toxin
Tennis Elbow

Treatments

Drug: Botox (drug)

Study type

Interventional

Funder types

Other

Identifiers

NCT00395616
e120537192

Details and patient eligibility

About

Humeral lateral epicondylitis or tennis elbow is a common painful elbow disorder. The cause of tennis elbow is the chronic overload of bone-tendon junction. High prevalence of tennis elbow has a direct impact on the workplace productivity and quality of life. Steroid injection is the very few methods proved to have short-term efficacy in tennis elbow treatment, but it has potential adverse effects like tendon rupture. Temporary paralysis of muscle after botulinum toxin injection may reduce the physical demands and facilitate the normal repair mechanism during recovery. Preliminary studies suggested that botulinum toxin injection is effective in treating tennis elbow. The objective of this study is to compare the effects of botulinum toxin injection with corticosteroid injection in tennis elbow treatment.

Sex

All

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pain at the lateral epicondyle of the elbow
  • Tenderness at the lateral epicondyle of the elbow
  • Pain on resisted extension of the wrist

Exclusion criteria

  • Local injection of steroid within 3 months
  • Previous elbow trauma or operations
  • Pregnancy
  • Systemic neuromuscular disorders such as myasthenia gravis

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Central trial contact

Yu-Ching Lin, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems